Cargando…
Outcomes of concomitant percutaneous coronary interventions and transcatheter aortic valve replacement
INTRODUCTION: Coronary artery disease is a common diagnosis among patients undergoing transcatheter aortic valve replacement (TAVR). The treatment and timing of percutaneous coronary intervention (PCI) remain controversial. We sought to compare in-hospital periprocedural outcomes of combined TAVR an...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885813/ https://www.ncbi.nlm.nih.gov/pubmed/33644487 http://dx.doi.org/10.5114/amsad.2020.103092 |
_version_ | 1783651676913139712 |
---|---|
author | Ghrair, Fadi Omran, Jad Thomas, Joseph Gifft, Kristina Allaham, Haytham Eniezat, Mohammad Kumar, Arun Enezate, Tariq |
author_facet | Ghrair, Fadi Omran, Jad Thomas, Joseph Gifft, Kristina Allaham, Haytham Eniezat, Mohammad Kumar, Arun Enezate, Tariq |
author_sort | Ghrair, Fadi |
collection | PubMed |
description | INTRODUCTION: Coronary artery disease is a common diagnosis among patients undergoing transcatheter aortic valve replacement (TAVR). The treatment and timing of percutaneous coronary intervention (PCI) remain controversial. We sought to compare in-hospital periprocedural outcomes of combined TAVR and PCI during the same index hospitalization versus the isolated TAVR procedure. MATERIAL AND METHODS: The study population was extracted from the 2016 Nationwide Readmissions Data (NRD) using International Classification of Diseases, tenth edition, clinical modifications/procedure coding system codes for TAVR, coronary PCI, and post-procedural complications. Study endpoints included in-hospital all-cause mortality, length of index hospital stay, cardiogenic shock, need for mechanical circulatory support (MCS) devices, mechanical complications of prosthetic valve, paravalvular leak (PVL), acute kidney injury (AKI), bleeding and total hospital charges. Propensity matching was used to adjust for baseline characteristics. RESULTS: There were 23,604 TAVRs in the 2016 NRD, of which 852 were combined with PCI during the same index hospitalization. Mean age was 80.5 years and 45.9% were female. In comparison to isolated TAVR, TAVR-PCI was associated with higher in-hospital all-cause mortality (4.5% vs. 1.7%, p < 0.01), longer length of stay (10.5 vs. 5.4 days, p < 0.01), and higher incidence of cardiogenic shock (9.4% vs. 2.1%, p < 0.01), use of MCS devices (6.8% vs. 0.7%, p < 0.01), mechanical complications of prosthetic valve (6.8% vs. 0.7%, p < 0.01), PVL (0.9% vs. 0.4%, p = 0.01), AKI (25.5% vs. 11.5%, p < 0.01), bleeding (25.2% vs. 18.1%, p < 0.01), and total hospital charges ($354,725 vs. $220474, p < 0.01). CONCLUSIONS: In comparison to isolated TAVR, combined TAVR-PCI was associated with a higher incidence of in-hospital morbidity and mortality. The association and mechanism of increased mortality warrant further study. |
format | Online Article Text |
id | pubmed-7885813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-78858132021-02-26 Outcomes of concomitant percutaneous coronary interventions and transcatheter aortic valve replacement Ghrair, Fadi Omran, Jad Thomas, Joseph Gifft, Kristina Allaham, Haytham Eniezat, Mohammad Kumar, Arun Enezate, Tariq Arch Med Sci Atheroscler Dis Clinical Research INTRODUCTION: Coronary artery disease is a common diagnosis among patients undergoing transcatheter aortic valve replacement (TAVR). The treatment and timing of percutaneous coronary intervention (PCI) remain controversial. We sought to compare in-hospital periprocedural outcomes of combined TAVR and PCI during the same index hospitalization versus the isolated TAVR procedure. MATERIAL AND METHODS: The study population was extracted from the 2016 Nationwide Readmissions Data (NRD) using International Classification of Diseases, tenth edition, clinical modifications/procedure coding system codes for TAVR, coronary PCI, and post-procedural complications. Study endpoints included in-hospital all-cause mortality, length of index hospital stay, cardiogenic shock, need for mechanical circulatory support (MCS) devices, mechanical complications of prosthetic valve, paravalvular leak (PVL), acute kidney injury (AKI), bleeding and total hospital charges. Propensity matching was used to adjust for baseline characteristics. RESULTS: There were 23,604 TAVRs in the 2016 NRD, of which 852 were combined with PCI during the same index hospitalization. Mean age was 80.5 years and 45.9% were female. In comparison to isolated TAVR, TAVR-PCI was associated with higher in-hospital all-cause mortality (4.5% vs. 1.7%, p < 0.01), longer length of stay (10.5 vs. 5.4 days, p < 0.01), and higher incidence of cardiogenic shock (9.4% vs. 2.1%, p < 0.01), use of MCS devices (6.8% vs. 0.7%, p < 0.01), mechanical complications of prosthetic valve (6.8% vs. 0.7%, p < 0.01), PVL (0.9% vs. 0.4%, p = 0.01), AKI (25.5% vs. 11.5%, p < 0.01), bleeding (25.2% vs. 18.1%, p < 0.01), and total hospital charges ($354,725 vs. $220474, p < 0.01). CONCLUSIONS: In comparison to isolated TAVR, combined TAVR-PCI was associated with a higher incidence of in-hospital morbidity and mortality. The association and mechanism of increased mortality warrant further study. Termedia Publishing House 2020-12-27 /pmc/articles/PMC7885813/ /pubmed/33644487 http://dx.doi.org/10.5114/amsad.2020.103092 Text en Copyright: © 2020 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Clinical Research Ghrair, Fadi Omran, Jad Thomas, Joseph Gifft, Kristina Allaham, Haytham Eniezat, Mohammad Kumar, Arun Enezate, Tariq Outcomes of concomitant percutaneous coronary interventions and transcatheter aortic valve replacement |
title | Outcomes of concomitant percutaneous coronary interventions and transcatheter aortic valve replacement |
title_full | Outcomes of concomitant percutaneous coronary interventions and transcatheter aortic valve replacement |
title_fullStr | Outcomes of concomitant percutaneous coronary interventions and transcatheter aortic valve replacement |
title_full_unstemmed | Outcomes of concomitant percutaneous coronary interventions and transcatheter aortic valve replacement |
title_short | Outcomes of concomitant percutaneous coronary interventions and transcatheter aortic valve replacement |
title_sort | outcomes of concomitant percutaneous coronary interventions and transcatheter aortic valve replacement |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885813/ https://www.ncbi.nlm.nih.gov/pubmed/33644487 http://dx.doi.org/10.5114/amsad.2020.103092 |
work_keys_str_mv | AT ghrairfadi outcomesofconcomitantpercutaneouscoronaryinterventionsandtranscatheteraorticvalvereplacement AT omranjad outcomesofconcomitantpercutaneouscoronaryinterventionsandtranscatheteraorticvalvereplacement AT thomasjoseph outcomesofconcomitantpercutaneouscoronaryinterventionsandtranscatheteraorticvalvereplacement AT gifftkristina outcomesofconcomitantpercutaneouscoronaryinterventionsandtranscatheteraorticvalvereplacement AT allahamhaytham outcomesofconcomitantpercutaneouscoronaryinterventionsandtranscatheteraorticvalvereplacement AT eniezatmohammad outcomesofconcomitantpercutaneouscoronaryinterventionsandtranscatheteraorticvalvereplacement AT kumararun outcomesofconcomitantpercutaneouscoronaryinterventionsandtranscatheteraorticvalvereplacement AT enezatetariq outcomesofconcomitantpercutaneouscoronaryinterventionsandtranscatheteraorticvalvereplacement |